Hangzhou Huajin Pharmaceutical Co., Ltd. was founded in 1995. It is a national high-tech enterprise integrating research, development, production and sales of biotechnology, biochemical drugs, raw materials and pharmaceutical intermediates. It has provincial high-tech enterprise research and development center, biochemical drug extraction production line and capsule production line in line with GMP requirements, and has a number of national invention patents. It covers an area of 50 mu, with a plant area of more than 14000 square meters.
The company mainly produces hepatocyte growth promoting factor enteric coated capsules, transfer factor capsules, pearl powder capsules and other finished products. In addition, there are dozens of finished drugs, raw materials and pharmaceutical intermediates such as thymosin, bovine bile extract, cerebroprotein hydrolysate, and anti-toxic bovine liver extract, which have been sold to more than 20 countries and regions around the world, with a good market. Among them, hepatocyte growth promoting factor enteric coated capsules were registered and listed in Korea and Georgia; cerebroprotein hydrolysate solution was successfully registered in Korea; and brain protein hydrolysate dry powder was successfully registered in Uzbekistan.
Since its establishment, the company adheres to scientific and technological innovation and improvement of product quality standards in accordance with the development requirements of biological medicine. In particular, the self-developed product "hepatocyte growth promoting factor enteric coated capsule" is an exclusive product in China. Its pharmacology is unique, its curative effect on improving white protein is obvious, and it is safe and reliable. Since it came into the market, it has been affirmed by liver disease experts and patients in China, and has been determined as a key recommended product by Zhejiang Province. At present, "hepatocyte growth promoting factor enteric coated capsules" has been listed in the medical insurance catalogue of Guangdong, Guangxi, Shanxi, Ningxia, Guizhou, Hunan, Inner Mongolia, Hainan and other provinces. The company's peptide biochemical products, with advanced extraction technology, high purity, strong activity and good safety, are welcomed by users. The company's raw materials, cerebroprotein hydrolysate and hepatocyte growth promoting factor, have high product quality standards, leading the industry level. The company has been invited by the national pharmacopoeia committee to participate in the quality standard improvement of some biochemical drugs.
The company has carried out scientific and technological cooperation with Chinese Academy of Sciences and Zhejiang University for a long time. At present, it has a provincial high-tech enterprise research and development center of "Huajin biomedical" and more than 10 patents on the preparation process of hepatocyte growth promoting factor enteric coated capsules. Several projects have been funded by national, provincial and municipal science and technology funds. Since 2003, the company has been recognized as a "national high-tech enterprise".
The company adheres to the concept of "treating the drug as parents, brothers and sisters" and always adheres to product quality. Since 2007, the company has been awarded the highest level "AA level" by Hangzhou food and drug administration. The company has a number of trademarks, among which "Huajin biology" has been awarded Hangzhou famous trademark by Hangzhou city. The company was awarded by Zhejiang Provincial Administration for Industry and commerce "provincial industrial and commercial enterprises abide by contracts and keep promises AAA level units". In June 2008, the Korean Drug Administration organized an expert group to conduct on-site verification of Cerebroprotein hydrolysis of our company, and the registration was successful on January 2, 2020. In April 2020, the company passed the ISO9001 quality system certification.